Technology News and Research

RSS

Experimental gene therapy shows promise for treating herpes infections

Researchers at Fred Hutch Cancer Center have found in pre-clinical studies that an experimental gene therapy for genital and oral herpes removed 90% or more of the infection and suppressed how much virus can be released from an infected individual, which suggests that the therapy would also reduce the spread of the virus.

13 May 2024

Breakthrough research reveals potential path toward a cure for ALS

In a groundbreaking Canadian discovery powered by philanthropy, a team of Western University researchers led by Dr. Michael Strong has uncovered a potential path toward a cure for amyotrophic lateral sclerosis (ALS).

13 May 2024

New study highlights recovery potential after traumatic brain injury

A new study in the peer-reviewed Journal of Neurotrauma found that more than 30% of patients with traumatic brain injury (TBI) for whom withdrawal of life sustaining treatment (WLST) was not performed recovered at least partial independence.

13 May 2024

Soft ERG multi-electrode system developed for enhanced eye disease monitoring

Eye diseases are becoming more prevalent worldwide, partly because of the aging population, but also because of our greatly increased screen time compared to previous generations.

13 May 2024

Research collaboration could help promote health and reduce injuries in NBA G League players

National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next Gen Basketball Players Union (NBGPU) in collaboration with GE HealthCare and MedStar Health today announced the completion of the data collection phase of a longitudinal pilot study of NBA G League players.

13 May 2024

Measles vaccine more likely to be completely ineffective in children born by C-section

A study by the University of Cambridge, UK, and Fudan University, China, has found that a single dose of the measles jab is up to 2.6 times more likely to be completely ineffective in children born by C-section, compared to those born naturally.

13 May 2024

Wearable biosensors with skin interfaces for newborn and neonatal health monitoring

Recent improvements in newborn wearable systems, concentrating on skin-interfaced wearables for physiological monitoring across many branches.

13 May 2024

ArgusEye closes €2.8 million funding to accelerate bioprocessing

ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the close of its funding, raising €2.8 million EUR (~£2.4 million GBP) bringing the total raised by the Company to €3.45 million EUR (~£3 million GPB).

From ArgusEye AB 13 May 2024

ERS Genomics appoints John E Milad as Chief Executive Officer

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences and medical technology sectors.

From ERS Genomics 13 May 2024

Research validates anti-inflammatory properties of wine using urinary tartaric acid as biomarker

The anti-inflammatory effects of wine by analyzing the relationship between urinary tartaric acid concentrations and changes in serum inflammatory biomarkers.

13 May 2024

Bats in China found to carry novel herpesviruses, hinting at cross-species transmission dangers

Researchers in Wuhan, China, have identified new strains ofβ and γ-herpesviruses in bats. These findings reveal potential cross-species transmission risks and emphasize the need for vigilant monitoring of bat populations to prevent zoonotic diseases.

13 May 2024

New biomedical engineering innovation shows potential to transform trauma care and surgical practices

A breakthrough study, published in Science Translational Medicine, features a biomedical engineering innovation with the potential to transform trauma care and surgical practices.

10 May 2024

New collaboration to combat river blindness and lymphatic filariasis

Prof. Achim Hoerauf, Director of the Institute of Medical Microbiology, Immunology and Parasitology at the University Hospital Bonn (UKB), and his team have succeeded in collaborating with the Department of Pharmaceutical Technology and Biopharmacy at the University of Bonn and the Helmholtz Center for Infection Research (HZI), to enter into a partnership with the Japanese pharmaceutical company Eisai for the further development of the antibiotic corallopyronin A (CorA) as a treatment for the neglected tropical diseases river blindness and lymphatic filariasis and to raise a large amount of funding.

10 May 2024

Study traces the origin and spread of HIV in Indonesia

The HIV variant dominant in Indonesia was introduced from Thailand over multiple events.

10 May 2024

Machine learning enables cheaper and safer low-power MRI

Machine learning enables cheaper and safer low-power magnetic resonance imaging (MRI) without sacrificing accuracy, according to a new study.

10 May 2024

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) for the treatment of patients with recurrent or metastatic cervical cancer who have progressed on or after chemotherapy. This marks a significant advancement in the therapeutic landscape for cervical cancer, highlighting the potential of antibody-drug conjugates (ADCs) in oncology.

10 May 2024

Research exposes water, sanitation inaccessibility for homeless and drug users during the pandemic

A defining development of the 20th century that changed the course of public health was when governments around the world improved access to safe water, sanitation and hygiene.

9 May 2024

Exploring microbiome dynamics in esophageal cancer

Esophageal cancer (EC) has two primary subtypes: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC).

9 May 2024

Enhancing the ability of natural killer cells to combat hematologic malignancies

A new study reveals a groundbreaking approach to immunotherapy, demonstrating that blocking the interaction between the CD300A receptor and phosphatidylserine (PS) significantly enhances the ability of human natural killer (NK) cells to lyse hematologic malignancies (HMs).

9 May 2024

New modular epigenome editing platform sheds light on gene regulation mechanisms

Understanding how genes are regulated at the molecular level is a central challenge in modern biology.

9 May 2024

1
2
3
4
...
2648
Next

Technology News and Research

Experimental gene therapy shows promise for treating herpes infections

Breakthrough research reveals potential path toward a cure for ALS

New study highlights recovery potential after traumatic brain injury

Soft ERG multi-electrode system developed for enhanced eye disease monitoring

Research collaboration could help promote health and reduce injuries in NBA G League players

Measles vaccine more likely to be completely ineffective in children born by C-section

Wearable biosensors with skin interfaces for newborn and neonatal health monitoring

ArgusEye closes €2.8 million funding to accelerate bioprocessing

ERS Genomics appoints John E Milad as Chief Executive Officer

Research validates anti-inflammatory properties of wine using urinary tartaric acid as biomarker

Bats in China found to carry novel herpesviruses, hinting at cross-species transmission dangers

New biomedical engineering innovation shows potential to transform trauma care and surgical practices

New collaboration to combat river blindness and lymphatic filariasis

Study traces the origin and spread of HIV in Indonesia

Machine learning enables cheaper and safer low-power MRI

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

Research exposes water, sanitation inaccessibility for homeless and drug users during the pandemic

Exploring microbiome dynamics in esophageal cancer

Enhancing the ability of natural killer cells to combat hematologic malignancies

New modular epigenome editing platform sheds light on gene regulation mechanisms

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News